As of my last knowledge update, Walgreens Boots Alliance (WBA) has not yet released its Q2 2025 earnings report. However, based on historical trends and recent developments, here’s what to expect: Expected Walgreens (WBA) Q2 2025 Earnings Overview Earnings Release Date: Likely late March or early April 2025 (exact date TBA). Previous Quarter (Q1 2025) Recap: Revenue: ~$36-37B (slight YoY decline). … Read more
Eli Lilly’s Obesity Pill Orforglipron Challenges Novo Nordisk’s Oral Wegovy in Weight-Loss Market Race August 24, 2025 The obesity drug market, projected to surpass $73 billion by 2034, is witnessing a fierce competition between pharmaceutical giants Eli Lilly and Novo Nordisk. Eli Lilly’s oral GLP-1 receptor agonist, orforglipron, is emerging as a significant rival to … Read more
Biotechnology giant Amgen Inc. has announced a major investment exceeding $600 million to construct a state-of-the-art research and development (R&D) center at its global headquarters in Thousand Oaks, California. This move underscores the company’s commitment to advancing scientific innovation amid a shifting U.S. pharmaceutical landscape, where domestic investments are surging in response to potential trade … Read more
Eli Lilly’s $5 Billion Bet on Virginia: A Game-Changer for U.S. Drug Manufacturing In a bold move to fortify America’s pharmaceutical backbone amid looming trade tensions and surging demand for cutting-edge therapies, Eli Lilly and Company announced plans on September 16, 2025, to invest $5 billion in a state-of-the-art manufacturing facility in Goochland County, Virginia—just … Read more